COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 191.9 | 9 | 0108-0576 | 608.85 | 576.94 | 389 | 74.91 | 0.871 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 216.8 | 9 | 0109-0587 | 590.60 | 587.81 | 393 | 75.26 | 0.872 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 193.2 | 9 | 0110-0594 | 360.80 | 594.71 | 372 | 72.67 | 0.885 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 175.0 | 9 | 0111-0597 | 50.96 | 597.50 | 346 | 71.01 | 0.862 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1845.5 | 9 | 0112-0619 | 538.40 | 618.84 | 271 | 59.94 | 0.948 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 247.6 | 9 | 0113-0632 | 114.79 | 632.78 | 368 | 71.84 | 0.896 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 199.1 | 9 | 0114-0633 | 916.89 | 632.73 | 349 | 70.77 | 0.876 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 223.5 | 9 | 0115-0637 | 723.10 | 636.85 | 398 | 76.08 | 0.864 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 241.7 | 9 | 0116-0635 | 35.78 | 635.56 | 114 | 43.46 | 0.759 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 226.4 | 9 | 0117-0647 | 330.91 | 646.43 | 963 | 121.30 | 0.823 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 238.3 | 9 | 0118-0643 | 95.21 | 643.10 | 364 | 74.08 | 0.833 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 249.0 | 9 | 0119-0646 | 831.47 | 646.01 | 365 | 71.84 | 0.889 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 243.2 | 9 | 0120-0664 | 884.80 | 664.40 | 591 | 92.33 | 0.871 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 605.2 | 9 | 0121-0688 | 282.03 | 688.56 | 384 | 75.84 | 0.839 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 183.8 | 9 | 0122-0691 | 32.07 | 691.03 | 364 | 72.43 | 0.872 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 219.3 | 9 | 0123-0696 | 492.71 | 697.00 | 914 | 118.23 | 0.822 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 199.2 | 9 | 0124-0692 | 101.63 | 692.07 | 400 | 76.08 | 0.868 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 254.1 | 9 | 0125-0695 | 371.28 | 694.61 | 380 | 75.50 | 0.838 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 457.7 | 9 | 0126-0700 | 602.27 | 699.55 | 456 | 83.74 | 0.817 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 203.4 | 9 | 0127-0701 | 453.77 | 701.32 | 370 | 71.84 | 0.901 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 229.3 | 1 | 0001-0030 | 110.32 | 30.57 | 334 | 66.77 | 0.941 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 530.3 | 1 | 0002-0030 | 292.69 | 29.76 | 335 | 69.70 | 0.867 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 212.8 | 1 | 0003-0033 | 788.07 | 32.87 | 308 | 63.94 | 0.947 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 219.9 | 1 | 0004-0036 | 632.11 | 35.77 | 388 | 76.67 | 0.829 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 214.9 | 1 | 0005-0039 | 856.44 | 39.34 | 340 | 71.26 | 0.842 |